Literature DB >> 24047633

Patients with testosterone deficit syndrome and depression.

Mohit Khera1.   

Abstract

Prevalence of depression in men increases with age, so does the prevalence of hypogonadism. Depression and anxiety are the most common psychopathological symptoms associated with male hypogonadism.The question is whether the age-related gradual decline in testosterone levels contributes to the rising rate of depression in older men. Many studies have demonstrated the improvement in depressive symptoms in hypogonadal men with testosterone supplementation. However, a subpopulation of hypogonadal men appear to be better responders to TRT when treated for depression. Testosterone deficiency is associated with numerous non-specific symptoms including decline in libido, erectile dysfunction, increased fat deposition, decreased muscle mass, decreased energy and depression. The relationship between increased depressive symptoms and declining testosterone levels is complex because many conditions are independently associated with depression and testosterone deficiency. These conditions include medical illnesses, such as HIV/AIDS, and obesity, stress, smoking, and alcohol abuse. While the literature does not support a consistent relationship between testosterone levels and depressive symptoms most studies do suggest that lower testosterone levels are associated with depressive symptoms. Furthermore, TRT has been shown to improve depressive symptoms in most men. This could be due to the fact that testosterone is a modulator of GABAA receptors and inhibits 5-HT3 receptors centrally. However there appears to be a subpopulation of depressed male patients that tend to respond best to TRT. These patients include men who have HIV/AIDS, mild depression, more severe testosterone deficiency, use transdermal testosterone as opposed to IM testosterone, and those not responding to SSRIs. However, patients taking SSRIs also experience a significant improvement in depressive symptoms once treated with TRT. Men with depressive symptoms and testosterone deficiency syndrome should be given a trial of testosterone replacement therapy for at least 3 months as TRT alone may improve clinical symptoms of depression. Furthermore, men already on SSRIs may also experience further improvement in depressive symptoms after initiating TRT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24047633

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  10 in total

1.  Viral-mediated Zif268 expression in the prefrontal cortex protects against gonadectomy-induced working memory, long-term memory, and social interaction deficits in male rats.

Authors:  Amanda M Dossat; Hussam Jourdi; Katherine N Wright; Caroline E Strong; Ambalika Sarkar; Mohamed Kabbaj
Journal:  Neuroscience       Date:  2016-11-02       Impact factor: 3.590

Review 2.  The association between diabetes and depression: a very disabling condition.

Authors:  Vincenzo Fiore; Massimo Marci; Antonella Poggi; Vito Angelo Giagulli; Brunella Licchelli; Massimo Iacoviello; Edoardo Guastamacchia; Giovanni De Pergola; Vincenzo Triggiani
Journal:  Endocrine       Date:  2014-06-14       Impact factor: 3.633

Review 3.  The practical management of testosterone deficiency in men.

Authors:  Antonio Aversa; Abraham Morgentaler
Journal:  Nat Rev Urol       Date:  2015-10-13       Impact factor: 14.432

Review 4.  On the effects of testosterone on brain behavioral functions.

Authors:  Peter Celec; Daniela Ostatníková; Július Hodosy
Journal:  Front Neurosci       Date:  2015-02-17       Impact factor: 4.677

Review 5.  The role of estradiol in male reproductive function.

Authors:  Michael Schulster; Aaron M Bernie; Ranjith Ramasamy
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

6.  Testing the social competition hypothesis of depression using a simple economic game.

Authors:  Aleksandra Kupferberg; Oliver M Hager; Urs Fischbacher; Laura S Brändle; Melanie Haynes; Gregor Hasler
Journal:  BJPsych Open       Date:  2016-03-24

7.  Administration of increasing doses of gonadotropin-releasing hormone in men with spinal cord injury to investigate dysfunction of the hypothalamic-pituitary-gonadal axis.

Authors:  William A Bauman; Michael F La Fountaine; Christopher M Cirnigliaro; Steven C Kirshblum; Ann M Spungen
Journal:  Spinal Cord       Date:  2017-11-15       Impact factor: 2.772

8.  High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.

Authors:  Georg S Kranz; Wolfgang Wadsak; Ulrike Kaufmann; Markus Savli; Pia Baldinger; Gregor Gryglewski; Daniela Haeusler; Marie Spies; Markus Mitterhauser; Siegfried Kasper; Rupert Lanzenberger
Journal:  Biol Psychiatry       Date:  2014-09-23       Impact factor: 13.382

Review 9.  The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.

Authors:  Grant L Iverson; C Dirk Keene; George Perry; Rudolph J Castellani
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  The Relationship between Selected Bioelements and Depressiveness Associated with Testosterone Deficiency Syndrome in Aging Men.

Authors:  Iwona Rotter; Adrian Wiatrak; Aleksandra Rył; Katarzyna Kotfis; Żaneta Ciosek; Maria Laszczyńska; Olimpia Sipak-Szmigiel; Aleksandra Szylińska
Journal:  Medicina (Kaunas)       Date:  2020-03-13       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.